相似文献
1
When the Treatment is the Cause: Disseminated Bacille Calmette-Guérin Infection.
Eur J Case Rep Intern Med. 2020 Jun 3;7(9):001697. doi: 10.12890/2020_001697. eCollection 2020.
2
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
3
Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review.
Pulmonology. 2020 Nov-Dec;26(6):346-352. doi: 10.1016/j.pulmoe.2019.10.001. Epub 2019 Nov 9.
4
[Miliary Pulmonary Tuberculosis After Intravesical BCG Instillation in a Patient with High-Grade Bladder Cancer].
Mikrobiyol Bul. 2023 Oct;57(4):675-681. doi: 10.5578/mb.20239955.
5
A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection.
Infect Agent Cancer. 2016 Jun 2;11:25. doi: 10.1186/s13027-016-0072-y. eCollection 2016.
6
Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy.
Cureus. 2022 Dec 30;14(12):e33134. doi: 10.7759/cureus.33134. eCollection 2022 Dec.
7
Miliary tuberculosis induced by intravesical instillation of bacillus Calmette-Guérin.
Radiologia (Engl Ed). 2019 Jul-Aug;61(4):337-340. doi: 10.1016/j.rx.2019.01.006. Epub 2019 Mar 18.
8
Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy.
Indian J Urol. 2013 Jan;29(1):64-6. doi: 10.4103/0970-1591.109989.
9
Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure.
Urol Case Rep. 2021 Mar 26;38:101655. doi: 10.1016/j.eucr.2021.101655. eCollection 2021 Sep.
10
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer.
Can Urol Assoc J. 2007 Sep;1(3):269-72. doi: 10.5489/cuaj.83.
本文引用的文献
1
Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.
Intern Med. 2017;56(12):1563-1567. doi: 10.2169/internalmedicine.56.8055. Epub 2017 Jun 15.
2
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
3
Detection of bacillus Galmette-Guérin (Mycobacterium bovis BCG) DNA in urine and blood specimens after intravesical immunotherapy for bladder carcinoma.
J Clin Microbiol. 2011 Apr;49(4):1206-8. doi: 10.1128/JCM.01595-10. Epub 2011 Jan 26.
4
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
J Urol. 2008 Jan;179(1):53-6. doi: 10.1016/j.juro.2007.08.122. Epub 2007 Nov 13.
5
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.
J Urol. 1992 Mar;147(3):596-600. doi: 10.1016/s0022-5347(17)37316-0.
Zotero 插件